The IDR Research team collaborates closely with administrative offices and research programs across the UF Health Science Center and main campus. IDR research services provide key data to multi-disciplinary research teams in support of scientific discoveries, grants, and publications.
The IDR research team collaborates closely with several other CTSI services in support of clinical and translational research.
Led by Dr. Bill Hogan, collaborate closely with the IDR research team. They provide informatics expertise and leadership to the ongoing growth and development of the UF Health IDR.
Led by PI Dr. Betsy Shenkman, the OneFlorida Clinical Research Consortium collaborates closely with the IDR research team. The IDR research team delivers UF Health patient data to OneFlorida, and manages OneFlorida’s i2b2 service for statewide cohort discovery.
(UFHCC) and its members are dedicated to providing leading-edge cancer care and conducting original research for the prevention, early diagnosis and treatment of cancer.
Inherent to the IDR is the honest broker processes designed with the UF IRB and UF Health Privacy Office to comply with standards for compliance, privacy, legality, information security and informatics. This approach enables a straightforward IRB data request process to have an honest broker release identified data for recruitment and other purposes as approved.
The IDR research team works with the UF IRB to ensure that access to data abides the principles of the “honest broker” practice and ensures that access to human subject data is in accordance with all federal, institutional and ethical guidelines.
The OCR is responsible for rethinking the way clinical research happens at the University of Florida, supporting the diverse portfolio of clinical research and health-related human subjects research across all colleges.
Led by Dr. Janice Krieger, improves human health and well-being by using messages to make scientific research more accessible, understandable and actionable.
The program screens patients genetic information to determine whether a specific drug can be used successfully. Researchers in the program have led seven clinical implementations for gene-drug pairs, supporting genotype-guided therapy and developing multiple education programs .
The research program from the National Institutes of Health (NIH). It is seeking one million or more people from across the U.S. to help speed up medical research and advance precision medicine to learn how our biology, lifestyle, and environment affect health.
Led by Dr. Azra Bihorac, is a collaborative research partnership for the design, development and implementation of Intelligent Healthcare Systems.
Led by Dr. Almut Winterstein, unites researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
Led by Dr. Jiang Bian, serves as a collaborative incubator at the University of Florida for research related to leveraging these and other emerging technologies with evidence-based research and clinical practices to improve health and health care.
Led by Dr. Patrick Tighe, examines how machine and deep learning algorithms, decision and process modeling, and social network analyses can improve processes related to acute postoperative pain, cognition, and perioperative patient safety.
Directed by Dr. David Fedele, and housed in the Department of Clinical and Health Psychology.